DAWN icon

Day One Biopharmaceuticals
DAWN

Overview Fund Activity

139 hedge funds and large institutions have $1.12B invested in Day One Biopharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 35 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
139
Holders Change
+9
Holders Change %
+6.92%
% of All Funds
2.04%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
26
Increased
51
Reduced
35
Closed
17
Calls
$1.66M
Puts
$575K
Net Calls
+$1.08M
Net Calls Change
+$1.05M

Top Buyers

1
Pictet Asset Management
1
Pictet Asset Management
Switzerland
$37.5M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$24.8M
3
TCM
3
TimesSquare Capital Management
New York
$24.3M
4
Morgan Stanley
4
Morgan Stanley
New York
$9.77M
5
B
5
Braidwell
Connecticut
$61.5M

Top Sellers

1
CPX
1
Canaan Partners XI
California
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$57.9M
3
NIP
3
Nicholas Investment Partners
California
$4.43M
4
PHS
4
PFM Health Sciences
California
$19M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$2.19M
Name Holding Trade Value Shares
Change 		Shares
Change %
CA
151
Crewe Advisors
Utah
– -$369 -30 Closed
Osaic Holdings
152
Osaic Holdings
Arizona
– -$294 -24 Closed
Northwestern Mutual Wealth Management
153
Northwestern Mutual Wealth Management
Wisconsin
– -$184 -15 Closed
3 4 5 6
7